Page last updated: 2024-08-23

epirubicin and Thyroid Cancer, Anaplastic

epirubicin has been researched along with Thyroid Cancer, Anaplastic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chen, M; Deng, W; Guo, P; Guo, W; Hao, J; Hu, S; Hua, Y; Li, W; Li, Y; Liao, Y; Long, Q; Sui, S; Sun, Y; Tian, C; Wang, R; Wang, X; Xie, F; Yu, W; Zhang, C; Zou, K; Zou, L; Zuo, Y1
Cartei, F; Cocuzza, P; Colosimo, C; Fiorica, F; Greco, C; Mazzotti, V; Pedriali, M; Stefanelli, A; Taibi, R; Ursino, S1

Reviews

1 review(s) available for epirubicin and Thyroid Cancer, Anaplastic

ArticleYear
Anaplastic thyroid cancer: a case report of a long term survival patient and review of literature data.
    European review for medical and pharmacological sciences, 2014, Volume: 18, Issue:9

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Epirubicin; Humans; Male; Middle Aged; Neoplasm Invasiveness; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Thyroidectomy; Time Factors; Tomography, X-Ray Computed; Treatment Outcome

2014

Other Studies

1 other study(ies) available for epirubicin and Thyroid Cancer, Anaplastic

ArticleYear
CRSP8 promotes thyroid cancer progression by antagonizing IKKα-induced cell differentiation.
    Cell death and differentiation, 2021, Volume: 28, Issue:4

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; Epirubicin; Gene Expression Regulation, Neoplastic; Humans; I-kappa B Kinase; Male; Mediator Complex; Mice; Mice, Inbred BALB C; Mice, Nude; Signal Transduction; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Xenograft Model Antitumor Assays

2021